ESSA Pharma to Present at the Jefferies Global Healthcare Conference
ESSA Pharma to Present at the Jefferies Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, May 30, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York.
加利福尼亚州南旧金山和不列颠哥伦比亚省温哥华，2024年5月30日 /PRNewswire/-专注于开发前列腺癌治疗新疗法的临床阶段制药公司ESSA Pharma Inc.（“ESSA” 或 “公司”）（纳斯达克股票代码：EPIX）今天宣布，该公司将于美国东部时间2024年6月6日星期四中午12点30分在纽约举行的杰富瑞全球医疗保健会议上发表演讲。
David. R. Parkinson, President, and Chief Executive Officer and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.
大卫。总裁兼首席执行官帕金森和首席财务官戴维·伍德将主持和参加一对一的会议。
A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days.
可以在ESSA网站的 “投资者/活动与演示” 部分观看该演示的网络直播，网址为。活动结束后，网络直播将在ESSA网站上存档90天。
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on Twitter and LinkedIn.
ESSA是一家临床阶段的制药公司，专注于开发用于治疗前列腺癌患者的新型专有疗法。欲了解更多信息，请访问 ，然后继续关注我们 推特 和 领英。
ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]
ESSA Pharma, Inc.
彼得·维尔西克，首席运营官
778.331.0962
[电子邮件保护]
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
投资者和媒体：
Argot Par
212.600.1902
essa@argotpartners.com
SOURCE ESSA Pharma Inc
来源 ESSA Pharma